Brain in Motion II Study
Summary
The Brain In Motion 2 Study is examining the relationship between exercise, cerebral blood flow, and cognition in older adults who are at increased risk of Alzheimer’s Disease and related dementias and the role that exercise might play in the prevention of cognitive decline.
We are looking for 264 individuals to volunteer in an 18-month randomized controlled trial, which includes either a six-month aerobic exercise program, or a six-month stretch and strength program. All parking expenses, as well as access and supervised training at the University of Calgary, Mount Royal University, or 1-2 other community-based facilities will be covered by the study.
Eligibility
Eligible ages: 50 to 80
Accepts healthy participants: Yes
Inclusion criteria:
1) The study is looking for participants who are sedentary. With one or more of the following:
a. A personal history of high blood pressure
b. A personal history of diabetes mellitus
c. Obesity
d. Elevated cholesterol
e. Current Smoker
f. Personal previous history of coronary artery disease
g. An immediate family member diagnosed with Alzheimer’s disease or dementia
(If you’re not sure about what your Fitness Level is, that’s okay; we can determine this through a telephone questionnaire conducted by one of our team members.)
2) In addition, the participants must have all of the following:
a. No history of dementia
b. Fluent in verbal and written English
c. No previous stroke or a mini-stroke (TIA)
Exclusion criteria:
Volunteers who engage in more than 150 minutes of moderate to vigorous aerobic activity per week.
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Please contact the study coordinator at 403.210.7315 or by email at bimstudy@ucalgary.ca, or the Principal Investigator Dr. Marc Poulin at 403.220.8372 or at poulin@ucalgary.ca
Principal investigator:
Marc Poulin
Clinical trial:
No
REB-ID:
REB16-1199
External links